Free Trial

Sanuwave Health (SNWV) Competitors

Sanuwave Health logo
$38.36 -0.25 (-0.65%)
As of 04:00 PM Eastern

SNWV vs. MDXG, ESTA, PLSE, BLFS, INMD, IRMD, TNDM, KMTS, SIBN, and BBNX

Should you be buying Sanuwave Health stock or one of its competitors? The main competitors of Sanuwave Health include MiMedx Group (MDXG), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), InMode (INMD), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Kestra Medical Technologies (KMTS), SiBone (SIBN), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry.

Sanuwave Health vs. Its Competitors

Sanuwave Health (NASDAQ:SNWV) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 14.9% of Sanuwave Health shares are held by company insiders. Comparatively, 1.7% of MiMedx Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sanuwave Health has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500.

MiMedx Group has a net margin of 8.84% compared to Sanuwave Health's net margin of -97.03%. MiMedx Group's return on equity of 23.03% beat Sanuwave Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanuwave Health-97.03% N/A -135.15%
MiMedx Group 8.84%23.03%17.09%

In the previous week, MiMedx Group had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 2 mentions for MiMedx Group and 1 mentions for Sanuwave Health. MiMedx Group's average media sentiment score of 1.71 beat Sanuwave Health's score of 1.05 indicating that MiMedx Group is being referred to more favorably in the news media.

Company Overall Sentiment
Sanuwave Health Positive
MiMedx Group Very Positive

Sanuwave Health presently has a consensus price target of $49.00, indicating a potential upside of 27.74%. MiMedx Group has a consensus price target of $12.00, indicating a potential upside of 66.90%. Given MiMedx Group's higher probable upside, analysts clearly believe MiMedx Group is more favorable than Sanuwave Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanuwave Health
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
MiMedx Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

MiMedx Group has higher revenue and earnings than Sanuwave Health. Sanuwave Health is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanuwave Health$32.63M10.07-$31.37M-$8.25-4.65
MiMedx Group$348.88M3.05$42.42M$0.2134.24

Summary

MiMedx Group beats Sanuwave Health on 12 of the 14 factors compared between the two stocks.

Get Sanuwave Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNWV vs. The Competition

MetricSanuwave HealthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$328.75M$10.48B$5.70B$9.79B
Dividend YieldN/A1.90%3.77%4.10%
P/E Ratio-4.6520.6730.8625.27
Price / Sales10.0731.09403.8888.61
Price / CashN/A24.9525.2228.45
Price / Book-25.743.459.516.00
Net Income-$31.37M$209.94M$3.26B$265.34M
7 Day Performance-10.25%3.96%4.50%2.79%
1 Month Performance-2.24%12.75%5.22%1.51%
1 Year PerformanceN/A-9.39%31.92%25.40%

Sanuwave Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNWV
Sanuwave Health
2.3787 of 5 stars
$38.36
-0.6%
$49.00
+27.7%
N/A$328.75M$32.63M-4.6540Gap Up
MDXG
MiMedx Group
3.1983 of 5 stars
$7.02
-1.3%
$12.00
+70.9%
+13.6%$1.05B$348.88M33.43870Positive News
ESTA
Establishment Labs
2.3121 of 5 stars
$34.80
-3.2%
$55.80
+60.3%
-9.2%$1.04B$166.02M-11.411,018Analyst Downgrade
High Trading Volume
PLSE
Pulse Biosciences
3.7007 of 5 stars
$14.71
-0.1%
$22.00
+49.6%
-15.0%$990.27M$700K0.00140Earnings Report
BLFS
BioLife Solutions
3.4003 of 5 stars
$22.68
+9.9%
$31.29
+37.9%
-5.8%$987.32M$82.25M-188.98440Positive News
INMD
InMode
2.8149 of 5 stars
$14.11
-1.8%
$18.04
+27.9%
-10.3%$908.32M$394.82M5.71480News Coverage
Positive News
IRMD
iRadimed
4.5694 of 5 stars
$69.93
+1.4%
$72.00
+3.0%
+57.7%$877.30M$73.24M43.17110
TNDM
Tandem Diabetes Care
4.5673 of 5 stars
$11.23
-2.5%
$23.43
+108.6%
-75.8%$778.40M$940.20M-3.632,650
KMTS
Kestra Medical Technologies
1.4967 of 5 stars
$14.52
-1.6%
$27.33
+88.2%
N/A$757.39M$59.81M0.00300
SIBN
SiBone
4.3673 of 5 stars
$15.68
-3.9%
$23.67
+50.9%
+11.5%$704.06M$167.18M-28.00350
BBNX
Beta Bionics
N/A$14.74
-2.3%
$22.56
+53.0%
N/A$655.96M$65.12M0.00294News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:SNWV) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners